Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study

BACKGROUND: Dexamethasone intravitreal implant (DEX implant) is a sustained-release biodegradable implant approved for treatment of macular edema associated with retinal vein occlusion (RVO). The safety and efficacy of treatment of RVO-associated macular edema with sequential DEX implants in clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Michael A, Capone Jr, Antonio, Dugel, Pravin U, Dreyer, Richard F, Dodwell, David G, Roth, Daniel B, Shi, Rui, Walt, John G, Scott, Lanita C, Hollander, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391088/
https://www.ncbi.nlm.nih.gov/pubmed/25885285
http://dx.doi.org/10.1186/s12886-015-0018-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391088/
https://www.ncbi.nlm.nih.gov/pubmed/25885285
http://dx.doi.org/10.1186/s12886-015-0018-y

Ejemplares similares